Annual Drug Patent Expirations for PEMAZYRE
Pemazyre is a drug marketed by Incyte Corp and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has eigthy-five patent family members in thirty-seven countries.
The generic ingredient in PEMAZYRE is pemigatinib. One supplier is listed for this compound. Additional details are available on the pemigatinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
